{
  "event_id": "ba28662e4d60",
  "ticker": "AMLX",
  "company_name": "Amylyx Pharmaceuticals",
  "drug_name": "AMX0035",
  "result": "withdrawn",
  "pdufa_date": "2022-09-29",
  "approval_type": {
    "status": "found",
    "value": "nda",
    "source": "websearch:CENTAUR Phase 2 (AdCom 7-2)",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.111742",
    "error": null
  },
  "indication": {
    "status": "found",
    "value": "Amyotrophic lateral sclerosis (ALS)",
    "source": "websearch:CENTAUR Phase 2 (AdCom 7-2)",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.111743",
    "error": null
  },
  "generic_name": {
    "status": "found",
    "value": "sodium phenylbutyrate/taurursodiol",
    "source": "websearch_fda",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T00:34:43.330127",
    "error": null
  },
  "therapeutic_area": {
    "status": "found",
    "value": "Neurology",
    "source": "websearch",
    "confidence": 0.85,
    "tier": 2,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T10:49:58.454126",
    "error": null
  },
  "mechanism_of_action": {
    "status": "found",
    "value": "Sodium phenylbutyrate/taurursodiol",
    "source": "legacy_migration",
    "confidence": 0.75,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": "2026-01-10T12:42:32.017774",
    "error": null,
    "note": null
  },
  "phase": {
    "status": "found",
    "value": "Withdrawn",
    "source": "websearch_clinical",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T00:34:43.330127",
    "error": null
  },
  "primary_endpoint_met": {
    "status": "found",
    "value": true,
    "source": "websearch:CENTAUR Phase 2 (AdCom 7-2)",
    "confidence": 0.85,
    "evidence": [
      "CENTAUR Phase 2 (AdCom 7-2)"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.111729",
    "error": null
  },
  "p_value": {
    "status": "found",
    "value": "0.03",
    "source": "websearch:CENTAUR Phase 2 (AdCom 7-2)",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.111737",
    "error": null
  },
  "effect_size": {
    "status": "found",
    "value": "ALSFRS-R decline slowed 25% (1.24 vs 1.66 pts/month); OS HR 0.64 in OLE",
    "source": "websearch:CENTAUR Phase 2 (AdCom 7-2)",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.111739",
    "error": null
  },
  "has_prior_crl": {
    "status": "not_applicable",
    "value": null,
    "source": "withdrawn",
    "confidence": 1.0,
    "evidence": [
      "Application withdrawn"
    ],
    "searched_sources": [
      "internal_dataset"
    ],
    "last_searched": "2026-01-09T21:29:37.609697",
    "error": null
  },
  "is_resubmission": {
    "status": "found",
    "value": 0,
    "source": "legacy_v12",
    "confidence": 0.75,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": null,
    "error": null
  },
  "pai_passed": {
    "status": "found",
    "value": true,
    "source": "derived_from_crl_reason",
    "confidence": 0.85,
    "tier": 2
  },
  "warning_letter": {
    "status": "found",
    "value": false,
    "source": "derived_from_crl_reason",
    "confidence": 0.75,
    "tier": 2
  },
  "safety_signal": {
    "status": "found",
    "value": false,
    "source": "derived_from_crl_reason",
    "confidence": 0.85,
    "tier": 2
  },
  "p_value_numeric": 0.03,
  "nct_ids": [
    "NCT03127514"
  ],
  "phase3_study_names": [
    "Evaluation of the Safety, Tolerability, Efficacy and Activity of AMX0035, a Fixed Combination of Phenylbutyrate (PB) and Tauroursodeoxycholic Acid (TUDCA), for the Treatment of ALS"
  ],
  "prior_crl_reason": {
    "status": "found",
    "value": "Confirmatory PHOENIX trial failed, voluntarily withdrawn",
    "source": "web_search",
    "category": "CLINICAL_DATA",
    "confidence": 0.9,
    "tier": 2
  },
  "enrollment": {
    "count": 137,
    "type": "ACTUAL",
    "nct_id": "NCT03127514",
    "source": "clinicaltrials.gov",
    "fetched_at": "2026-01-10T17:24:47.605654"
  },
  "fda_designations": {
    "breakthrough_therapy": true,
    "fast_track": true,
    "priority_review": true,
    "orphan_drug": true,
    "accelerated_approval": false
  },
  "adcom_info": {
    "scheduled": true,
    "held": true,
    "date": null,
    "outcome": "favorable",
    "vote_for": null,
    "vote_against": null
  },
  "is_single_arm": {
    "value": false,
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "interventionModel=PARALLEL",
      "allocation=RANDOMIZED"
    ],
    "searched_sources": [
      "clinicaltrials.gov"
    ],
    "last_searched": "2026-01-10T13:11:37.079318",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "trial_region": {
    "value": "us_only",
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "countries=['UNITED STATES']..."
    ],
    "searched_sources": [
      "clinicaltrials.gov"
    ],
    "last_searched": "2026-01-10T13:11:37.079346",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "is_biosimilar": {
    "value": false,
    "status": "found",
    "source": "approval_type_nda",
    "confidence": 0.9,
    "tier": 2,
    "evidence": [
      "approval_type=nda"
    ],
    "searched_sources": [
      "approval_type_nda"
    ],
    "last_searched": "2026-01-10T13:11:17.313882",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "is_first_in_class": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "crl_reason_type": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "warning_letter_date": {
    "value": null,
    "status": "confirmed_none",
    "source": "websearch_fda",
    "confidence": 0.7,
    "tier": 3,
    "evidence": [
      "No FDA warning letter found in search"
    ],
    "searched_sources": [
      "websearch_fda"
    ],
    "last_searched": "2026-01-11T04:13:22.557712",
    "error": null
  },
  "fda_483_date": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "fda_483_observations": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "cdmo_name": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "pai_date": {
    "value": null,
    "status": "not_found",
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T13:31:04.799322",
    "error": null,
    "note": null,
    "has_value": false,
    "needs_retry": true,
    "is_complete": false
  },
  "clinical_hold_history": {
    "value": null,
    "status": "confirmed_none",
    "source": "websearch_clinical_hold",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [
      "websearch_clinical_hold"
    ],
    "last_searched": "2026-01-10T13:31:05.812161",
    "error": null,
    "note": null,
    "has_value": false,
    "needs_retry": false,
    "is_complete": true
  },
  "days_to_pdufa": -1199,
  "pdufa_status": "past",
  "risk_tier": "HIGH",
  "days_calculated_at": "2026-01-10T16:59:37.268538",
  "original_case_id": "06b053e6b238",
  "data_quality_score": 0.075,
  "collected_at": "2026-01-09T00:31:09.359334",
  "enriched_at": "2026-01-11T17:33:08.376238",
  "needs_manual_review": false,
  "review_reasons": [],
  "migrated_at": "2026-01-10T12:42:32.017797",
  "schema_version": "3.0",
  "adcom_scheduled": {
    "value": true,
    "status": "found",
    "source": "websearch_adcom",
    "confidence": 0.75,
    "tier": 3,
    "evidence": [
      "FDA Committee, in Reversal, Favors AMX0035 Approval for ALS FDA advisers back Amylyx ALS drug, rever",
      "Vote ratio extracted: 77.8%",
      "FDA Advisory Committee Votes to Recommend AMX0035 for ..."
    ],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:33:08.376227"
  },
  "adcom_vote_ratio": {
    "value": 0.7777777777777778,
    "status": "found",
    "source": "websearch_adcom",
    "confidence": 0.7,
    "tier": 3,
    "evidence": [
      "FDA Committee, in Reversal, Favors AMX0035 Approval for ALS FDA advisers back Amylyx ALS drug, rever",
      "Vote ratio extracted: 77.8%",
      "FDA Advisory Committee Votes to Recommend AMX0035 for ..."
    ],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:33:08.376235"
  },
  "breakthrough_therapy": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:30:37.140201",
    "search_status": "CONFIRMED_NONE"
  },
  "priority_review": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "Dear FDA: Please Grant Priority Review to AMX0035 and Approve It"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:30:39.881090",
    "search_status": "FOUND"
  },
  "fast_track": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.85,
    "tier": 2,
    "evidence": [
      "Amylyx Pharmaceuticals Reports Second Quarter 2025 ... - BioSpace"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:30:41.304650",
    "search_status": "FOUND"
  },
  "orphan_drug": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "Amylyx Pharmaceuticals Receives Orphan Drug Designation From ..."
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:30:38.357453",
    "search_status": "FOUND"
  },
  "accelerated_approval": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "AMX0035 patents and clinical trials: Drug pipeline profiles ..."
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:30:45.873417",
    "search_status": "FOUND"
  }
}